Receive our newsletter – data, insights and analysis delivered to you
  1. Market Data
November 15, 2011

Abbott new hepatitis assay gets CE mark

Abbott's Architect hepatitis B surface antigen (HBsAg) diagnostic test has been awarded the CE mark.

Abbott’s Architect hepatitis B surface antigen (HBsAg) diagnostic test has been awarded the CE mark.

The HBsAg quantitative assay helps in the detection of acute and chronic Hepatitis B virus infections, and screens blood and blood products using the Architect immunochemistry system.

The test is a chemiluminescent microparticle immunoassay that enables clinicians to identify patients with low levels of HBsAg.

Biomnis biologist Thoai Duong Ly said that the Architect test helps to identify mutant strains of the Hepatitis B virus.

Related Companies

Content from our partners
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
The powerful networks advancing life sciences in Charleston | USA
The power of infrastructure: How Charleston | SC | USA is expanding horizons for life science companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU